The Latest Cardiac and Vascular News
SHENZHEN, China–(BUSINESS WIRE)–Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, today launches the mWear™ system, an all-new wearable patient monitoring solution that enables an efficient workflow to continually monitor patient conditions and deliver patient-centric care. With the increased shortages of beds and staff in today’s hospitals, […]
8 to 12 million people suffer from Heart failure in the country and only a fraction can afford treatment Azmarda (Saccubutril-Valsartan®), 50 mg will now be available at INR 39.6 per tablet as compared to INR 78 per tablet Move to increase affordability and accessibility for Heart failure patients across […]
Community Study successfully predicted heart failure events, increasing opportunities for preventative care NEW YORK, Nov. 29, 2022 /PRNewswire/ — Cordio Medical, a market-leading medical speech processing platform, shared key findings in the HearO™Community Study: Remote Speech Analysis of Hospitalized Patients with Acute Decompensated Heart Failure that assessed remote speech analysis through the Cordio HearO™application. Dr. William Abraham, […]
If approved, Evkeeza would be the first and only treatment of its kind to help children as young as 5 years old control dangerously high levels of LDL cholesterol caused by homozygous familial hypercholesterolemia TARRYTOWN, N.Y., Nov. 30, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has […]
London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system, Evolut™ FX, significantly improved commissure alignment during TAVR procedures compared to earlier generation Evolut systems. A late breaker presentation at PCR […]
The Cardiogenomics Clinic at the University of Alabama at Birmingham and Allelica are partnering to perform a clinical implementation study to assess how polygenic risk score integration changes clinical management and health outcomes in a US health system. NEW YORK, Nov. 29, 2022 /PRNewswire/ — The UAB Cardiogenomics Clinic, led by Dr. Pankaj Arora, is […]
VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIRA-II is the U.S. Investigational Device Exemption (“IDE”) pivotal clinical trial the Company is executing for the Neovasc Reducer™ (“Reducer”) towards an approval […]
GENT, Belgium–(BUSINESS WIRE)–Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguideTM result in an important change of pre-procedural decision making of the heart team, associated with favorable clinical outcomes. This prospective multicenter […]
LONDON, Nov. 27, 2022 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company’s EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes. The data were presented during the late-breaking trials session at PCR London […]
MARLBOROUGH, Mass., Nov. 27, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System. The findings, which included a high procedural success rate of 98.4% and low rates of mortality and paravalvular […]
